drugset / Trial / NCT03019081

Augmented Interoceptive Exposure Training in Anorexia Nervosa

NCT03019081

RandomizedParallel-groupDouble-blindTreatment

Summary

The researchers propose to utilize a pharmacological approach involving infusions of the sympathomimetic agent isoproterenol to repeatedly trigger cardiorespiratory sensations and anxiety during meal anticipation, to facilitate the development of tolerance or a reduction of the anxiety/fear response in individuals with anorexia nervosa. The investigators aim to conduct a proof of principle study to assess for evidence of initial efficacy of this new treatment approach. As a comparator condition, the researchers propose using repeated administration of saline infusions.

Timeline

Start
2017-01
Primary completion
2021-08
Completion
2024-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Isoproterenol Small molecule 0.1 ug Intravenous
Subject Isoproterenol Small molecule 4 ug Intravenous

Indications